- Home
- Publications
- Publication Search
- Publication Details
Title
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-24
DOI
10.3389/fonc.2021.785111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia
- (2021) Xiaotian Han et al. Frontiers in Oncology
- Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
- (2021) Maeva Dufies et al. Communications Biology
- Theasaponin E1 Inhibits Platinum-Resistant Ovarian Cancer Cells through Activating Apoptosis and Suppressing Angiogenesis
- (2021) Bo Li et al. MOLECULES
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
- (2021) Lan Dai et al. Journal of Ovarian Research
- Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
- (2021) Yingying Xing et al. Frontiers in Immunology
- Hypoxia-Induced MALAT1 Promotes the Proliferation and Migration of Breast Cancer Cells by Sponging MiR-3064-5p
- (2021) Chung-Hsien Shih et al. Frontiers in Oncology
- Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission
- (2021) Komal Tyagi et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Modeling hypoxia facilitates cancer cell survival through downregulation of p53 expression
- (2021) Yang Zhang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer
- (2021) Carolyn N. Krasner et al. GYNECOLOGIC ONCOLOGY
- Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness
- (2021) Bo Young Jeong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway
- (2020) Jing Zhao et al. Cell Death & Disease
- Ginsenoside 20(S)‐Rg3 upregulates HIF‐1α‐targeting miR‐519a‐5p to inhibit the Warburg effect in ovarian cancer cells
- (2020) Jiaojiao Lu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions
- (2020) Liyan Duan et al. Journal of Ovarian Research
- Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
- (2020) Yanfei Yang et al. Frontiers in Cell and Developmental Biology
- Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF‐α pathway
- (2020) Shan Su et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Glycolysis inhibition and apoptosis induction in human prostate cancer cells by FV-429-mediated regulation of AR-AKT-HK2 signaling network
- (2020) Xian Chen et al. FOOD AND CHEMICAL TOXICOLOGY
- Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p/S100A14 Axis
- (2020) Weiqiang Zhang et al. OncoTargets and Therapy
- A Positive Feedback Loop of lncRNA DSCR8/miR-98-5p/STAT3/HIF-1α Plays a Role in the Progression of Ovarian Cancer
- (2020) Lina Dong et al. Frontiers in Oncology
- Polyphenols Extracted from Chinese Hickory (Carya cathayensis) Promote Apoptosis and Inhibit Proliferation through the p53-Dependent Intrinsic and HIF-1α-VEGF Pathways in Ovarian Cancer Cells
- (2020) Zhiping He et al. Applied Sciences-Basel
- IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells
- (2020) Shiwen Xu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Multifocused Ultrasound Therapy for Controlled Microvascular Permeabilization and Improved Drug Delivery
- (2020) Lokesh Basavarajappa et al. IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL
- HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
- (2019) Ayako Nagao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
- (2019) Xiaolan Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis
- (2019) Suchitra Natarajan et al. CANCER RESEARCH
- Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b
- (2019) Jian-jun Zhang et al. ACTA PHARMACOLOGICA SINICA
- Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α
- (2019) Dan Liu et al. BIOSCIENCE REPORTS
- Epithelial ovarian cancer stem‑like cells are resistant to the cellular lysis of cytokine‑induced killer cells via HIF1A‑mediated downregulation of ICAM‑1
- (2019) Shixia Bu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- Long noncoding RNA CDKN2B-AS1 interacts with miR-411–3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway
- (2019) Yan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
- (2019) Jun Dai et al. Journal of Translational Medicine
- Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
- (2019) Ke Xu et al. MOLECULAR THERAPY
- Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells
- (2019) Jinling Huang et al. MEDICAL SCIENCE MONITOR
- Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments
- (2019) Yasna Contreras-Baeza et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression
- (2019) Shouhua Wang et al. Molecular Cancer
- MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis
- (2019) Chaoyang Sun et al. ONCOGENE
- SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer
- (2019) Tian Gao et al. CANCER LETTERS
- IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
- (2019) Jirui Wen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
- (2019) Peter C. Hart et al. Cell Reports
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer
- (2018) Imran Hussain et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
- (2018) Yan Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis
- (2018) Whitney R. Grither et al. ONCOGENE
- Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429
- (2018) Qinglong Guo et al. Cell Death & Disease
- The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
- (2018) Mustafa Yassin Taher et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy
- (2018) Yun Zhou et al. OncoImmunology
- Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
- (2017) Marta De Donato et al. GYNECOLOGIC ONCOLOGY
- Inhibitory Effects of Total Triterpenoid Saponins Isolated from the Seeds of the Tea Plant (Camellia sinensis) on Human Ovarian Cancer Cells
- (2017) Ling-Yan Jia et al. MOLECULES
- Role of Intestinal HIF-2α in Health and Disease
- (2016) Sadeesh K. Ramakrishnan et al. Annual Review of Physiology
- From Lead to Drug Utilizing a Mannich Reaction: The Topotecan Story
- (2016) Franz Bracher et al. ARCHIV DER PHARMAZIE
- Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche
- (2016) Fabrizio Miranda et al. CANCER CELL
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
- (2016) XIN LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity
- (2016) Fedora Grande et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T Cells
- (2016) Ting Zhang et al. ONCOLOGY RESEARCH
- Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer
- (2016) Anxin Gu et al. Reproductive Sciences
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 Complex
- (2016) Marek Adamowicz et al. Cell Reports
- The dual-functional capability of cytokine-induced killer cells and application in tumor immunology
- (2015) Qiang Zhang et al. HUMAN IMMUNOLOGY
- Effective activity of cytokine induced killer cells against hepatocellular carcinoma including tumor-initiating cells
- (2015) Xiaoxiang Rong et al. MEDICAL HYPOTHESES
- Structural integration in hypoxia-inducible factors
- (2015) Dalei Wu et al. NATURE
- Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells
- (2015) ZHIPING HE et al. ONCOLOGY REPORTS
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Interleukin-8 promotes human ovarian cancer cell migration by epithelial–mesenchymal transition induction in vitro
- (2014) J. Yin et al. Clinical & Translational Oncology
- Translational Impact of Nanoparticle-Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer
- (2014) E. Pham et al. CLINICAL CANCER RESEARCH
- Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells
- (2014) Noriyuki Takai et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Phase II trial of vorinostat in advanced melanoma
- (2014) N. B. Haas et al. INVESTIGATIONAL NEW DRUGS
- Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
- (2014) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
- (2014) Ting Liu et al. PLoS One
- The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
- (2014) Darren M. Hutt et al. PLoS One
- Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis
- (2014) Yue Jin et al. TUMOR BIOLOGY
- HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
- (2014) Elena Braicu et al. OncoTargets and Therapy
- Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling
- (2014) X Peng et al. Cell Death & Disease
- Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis
- (2014) Hyo Bae et al. Journal of Ovarian Research
- Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer
- (2013) Christopher R. Garrett et al. CANCER
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
- (2013) Yu-Ming Yeh et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer
- (2013) FANG JI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
- (2012) Eveline M. Dijkgraaf et al. CURRENT PHARMACEUTICAL DESIGN
- Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1α; and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer
- (2012) Ying Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HIF-1 versus HIF-2 — Is one more important than the other?
- (2012) Agnieszka Loboda et al. VASCULAR PHARMACOLOGY
- Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
- (2011) Puja Sapra et al. ANGIOGENESIS
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 in Advanced Solid Tumors
- (2011) S. Kummar et al. CLINICAL CANCER RESEARCH
- Effect of Obesity on Survival of Women With Epithelial Ovarian Cancer
- (2011) Hyun-Sik Yang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- The role of hypoxia inducible factor-1alpha in gynecological cancer
- (2010) Laura M.S. Seeber et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination
- (2010) Einar K. Rofstad et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
- (2010) Justine Yang Bruce et al. INVESTIGATIONAL NEW DRUGS
- A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
- (2010) Michael R. Harrison et al. INVESTIGATIONAL NEW DRUGS
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of 2 methoxyestradiol (Panzem ® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial
- (2009) Daniela Matei et al. GYNECOLOGIC ONCOLOGY
- Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
- (2009) A. Rapisarda et al. MOLECULAR CANCER THERAPEUTICS
- Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
- (2009) Wu-Yang Huang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
- (2008) Alexandros Daponte et al. BMC CANCER
- Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model
- (2008) P. Sapra et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
- (2008) E. I. Heath et al. CLINICAL CANCER RESEARCH
- The Human Protein Atlas-a tool for pathology
- (2008) F Pontén et al. JOURNAL OF PATHOLOGY
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now